Nikolaus Marx

机构：Novo Nordisk (Denmark), Universitätsklinikum Aachen, RWTH Aachen University · ORCID：0000-0001-6141-634X

发表论文 991 篇 · 总被引 54711 次 · h-index 88

代表论文

• C-reactive protein and cardiovascular risk in the general population (2025 · European Heart Journal · 被引 33)
• Rationale, Design, and Baseline Clinical Characteristics of the Ziltivekimab Cardiovascular Outcomes Trial (2025 · JAMA Cardiology · 被引 29)
• Prediabetes remission and cardiovascular morbidity and mortality: post-hoc analyses from the Diabetes Prevention Program Outcome study and the DaQing Diabetes Prevention Outcome study (2025 · The Lancet Diabetes & Endocrinology · 被引 18)
• Inflammatory Biomarkers in Heart Failure: Clinical Perspectives on hsCRP, IL-6 and Emerging Candidates (2025 · Current Heart Failure Reports · 被引 13)
• Impact of Oral Semaglutide on Kidney Outcomes in People With Type 2 Diabetes: Results From the SOUL Randomized Trial (2025 · Diabetes Care · 被引 8)
• PCSK9 inhibitor treatment and outcomes in patients with atherosclerotic cardiovascular disease but without prior ischaemic events: an observational study (2026 · European Heart Journal · 被引 3)